Skip to content

13F-HR filed by Boxer Capital, LLC

Boxer Capital, LLC filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 51 holding rows worth $1,768,107,000.

Accession
0000950123-20-002532
Filed
2020-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, 51 entries on the cover page, a total value of $1,768,107,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,768,107,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MIRATI THERAPEUTICS INC60468T105COM1,715,560$221,067,000thousands by filing date
IMMUNOMEDICS INC452907108COM8,450,000$178,802,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR925,000$153,328,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM3,363,377$109,142,000thousands by filing date
MEDICINES CO584688105COM967,000$82,137,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM2,075,905$79,902,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR6,384,598$68,315,000thousands by filing date
ALLAKOS INC01671P100COM675,000$64,368,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock975,000$58,139,000thousands by filing date
SEATTLE GENETICS INC812578102COM500,000$57,130,000thousands by filing date
UNIQURE NVN90064101SHS765,400$54,849,000thousands by filing date
DIREXION DAILY S&P BIOTECH BEAR 3X SHARES25460E539ETF2,885,000$35,630,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock2,185,000$34,152,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,466,051$33,367,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR200,000$32,104,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM225,000$29,034,000thousands by filing date
KADMON HLDGS INC48283N106COM6,205,882$28,113,000thousands by filing date
ATRECA INC04965G109COM1,733,583$26,819,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM350,000$25,267,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM800,000$24,496,000thousands by filing date
MATINAS BIOPHARMA HLDGS INC576810105COM10,188,312$23,127,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,325,000$22,646,000thousands by filing date
CABALETTA BIO INC12674W109COMMON STOCK1,566,361$21,882,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM250,000$21,138,000thousands by filing date
ANAPTYSBIO INC032724106COM1,300,000$21,125,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM250,000$19,873,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM3,000,000$18,210,000thousands by filing date
PREVAIL THERAPEUTICS INC74140Y101COM1,123,105$17,779,000thousands by filing date
Milestone Pharmaceuticals Inc59935V107COM1,102,194$17,646,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM1,672,233$16,890,000thousands by filing date
BARCLAYS BANK PLC06746P621IPTH SR B S&P1,000,000$15,120,000thousands by filing date
ARVINAS INC04335A105COM366,000$15,039,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM1,775,000$13,490,000thousands by filing date
NEOLEUKIN THERAPEUTICS INC64049K104COM1,009,255$12,434,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK300,000$11,700,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock844,789$11,616,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK2,775,000$11,516,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM482,495$10,709,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM4,800,000$10,368,000thousands by filing date
MEDICINES COMPANY584688905COM100,000$8,494,000thousands by filing datecall
SELECTA BIOSCIENCES INC816212104COM3,284,072$7,816,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM317,000$7,773,000thousands by filing date
MEI PHARMA INC55279B202COM NEW2,913,091$7,224,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock764,252$5,732,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock1,031,872$4,592,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM2,000,000$3,920,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM200,000$3,562,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A290,577$3,214,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2775,000$3,046,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM250,000$2,195,000thousands by filing date
CELLECTAR BIOSCIENCES INC15117F500COM PAR920,000$2,070,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-20-002532this filing2020-02-14acceptance time not in the bulk data set